Single-use systems streamline CGT manufacturing by reducing cleaning validation and enabling quick changeovers, essential for personalized medicine and multiproduct facilities. Automation and ...
Terumo and Charles River Laboratories have released data highlighting the effectiveness of Terumo’s BCT Finia automated system in streamlining the cell and gene therapy (CGT) manufacturing process.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results